Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

LMAT Relative to the S&P 500

LMAT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the LeMaitre Vascular Inc. (NASD:LMAT) seasonal charts above shows that a Buy Date of May 29 and a Sell Date of September 27 has resulted in a geometric average return of 14.17% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 8.84% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm’s lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre’s surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

To download LMAT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: LMAT